GLP-1 & Weight Loss

GLP-1 receptor agonists and metabolic peptides for weight management, appetite control, and glycemic regulation.

16 peptide guides in this category.

Semaglutide — GLP-1 receptor agonist for weight management and glycemic control
Tirzepatide — Dual GIP/GLP-1 receptor agonist for enhanced weight loss and metabolic control
Liraglutide — GLP-1 receptor agonist for weight management and type 2 diabetes control
Dulaglutide — Long-acting GLP-1 receptor agonist with once-weekly dosing
Exenatide — First-in-class GLP-1 receptor agonist, available in immediate and extended-release formulations
Retatrutide — Triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors
Cagrilintide — Long-acting amylin receptor agonist being developed in combination with semaglutide
Eloralintide — Selective long-acting amylin receptor agonist in clinical development for obesity
AOD-9604 — Modified fragment of human growth hormone specifically designed for fat loss without IGF-1 elevation
Fragment 176-191 — Growth hormone fragment that promotes fat loss without affecting insulin sensitivity
5-Amino-1MQ — NNMT inhibitor that enhances metabolic function and promotes fat loss
Lipo-B (MIC) — Lipotropic injection combining methionine, inositol, choline with B vitamins
Lipo-C — Enhanced lipotropic with added L-carnitine for fat metabolism
Tesofensine — Triple monoamine reuptake inhibitor for weight loss
Survodutide — Dual GLP-1/glucagon receptor agonist for metabolic optimization
Mazdutide — Triple receptor agonist targeting GLP-1, GIP, and glucagon

Educational reference only — not medical advice. Work with a qualified clinician.